pentazocine and naloxone

Product NDC
63304-506
11-digit product format
633040506
Labeler code
63304
Product ID
63304-506_48ee2bd7-f7c9-4bf8-8932-ba9065c64cf3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
pentazocine and naloxone
Dosage form
TABLET
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA075523
Marketing category
ANDA
Marketing start
2018-07-31
Substance
NALOXONE HYDROCHLORIDE; PENTAZOCINE
Active strength
.5; 50 mg/1; mg/1
Pharmacologic classes
Competitive Opioid Antagonists [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
pentazocine and naloxone
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NALOXONE HYDROCHLORIDE.5 mg/1
PENTAZOCINE50 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiF850569PQR, RP4A60D26L
Rxcui312289

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c955d208-c333-9bd7-be34-d7e12986d44eProduct name620250626
e5f98bfa-66d5-4c3a-b22d-9543d3bee304Product name120250204
caa6391e-3db3-c912-335f-61b5fc00aa12Product name920240110
65a3bc34-04ff-4cf1-aad9-c7d92a062f6dProduct name120231003
e951cdf3-f269-4d97-a7d5-c1c3d7283a7dProduct name320230313
ab841ac7-728a-4fc9-be0a-35b96cecbf39Product name420230306
f327b80c-8fa2-404b-838a-df3eec141cf2Product name120221212
d4aa2fcf-79c3-4b5f-a00e-1a8e26e00119Product name120220511
b871fccd-1de6-4c7f-b9e5-045304641ee6Product name820220118
43b1efe2-1425-4b3e-b3a2-57d40f8478b9Product name120211026
4c23a34c-e8fc-424c-8fa0-ee064ba6eaefProduct name120170706
0b8c7273-1da3-495f-909a-7cf1e96d2361Product name120161212
3df867ed-9d48-45cf-bded-1394beaea0b1Product name320161206
8a245632-e24f-4ccc-b671-995d89c96ebcProduct name120141203
35c9f831-b55b-8fa5-36b8-614b5af2a2abProduct name120140508
96c5169b-5b9d-547d-bf22-d688d91866e4Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63304-506-01pentazocine and naloxone100 in 1 BOTTLETABLET1002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63304-506PENTAZOCINE AND NALOXONE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.]2Current NDC, Legacy NDC, 1 package rows20180731_41ebdaaf-3bbc-419f-b996-0341efc14623.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312289pentazocine 50 MG / naloxone 0.5 MG Oral TabletPSN41ebdaaf-3bbc-419f-b996-0341efc146232
312289naloxone 0.5 MG / pentazocine 50 MG Oral TabletSCD41ebdaaf-3bbc-419f-b996-0341efc146232
312289naloxone (as naloxone hydrochloride) 0.5 MG / pentazocine (as pentazocine hydrochloride) 50 MG Oral TabletSY41ebdaaf-3bbc-419f-b996-0341efc146232

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63304-506-0163304050601100 TABLET in 1 BOTTLE (63304-506-01) 100 tablet2018-07-310000-00-00NoNoCurrent